Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study

Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study

Background Intratumoral administration of V937, a bioselected, genetically unmodified coxsackievirus A21, has previously demonstrated antitumor activity in patients with advanced melanoma as monotherapy and in combination with the programmed cell death 1 (PD-1) antibody pembrolizumab. We report resu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Gregory A Daniels, Sigrun Hallmeyer, Mark Grose, Jon Richards, Mark Faries, Brendan D Curti, Kim A Margolin, Yiwei Zhang, Lynn Feun, Anlong Li, John R Hyngstrom, Robert H I Andtbacka
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-12-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/10/12/e005224.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dramatic Responses to High-Dose Ipilimumab Plus Temozolomide After Progression on Standard- or Low-Dose Ipilimumab in Advanced Melanoma
by: Julie Williamson, et al.
Published: (2025-02-01)

Exploring Bacteria‐Based Cancer Immunotherapy: Comment on “Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics”
by: Chen‐xi Li, et al.
Published: (2025-08-01)

Oncolytic Viruses
by: Nanhai G. Chen, et al.
Published: (2012-01-01)

Reply to “Exploring Bacteria‐Based Cancer Immunotherapy”—Comment on “Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics”
by: Eijiro Miyako
Published: (2025-08-01)

Preclinical and clinical evaluation of intratumoral injection of an IL-12 expressing SKV-012 oncolytic virus for advanced solid tumors
by: Jing Jin, et al.
Published: (2025-06-01)

Heterologous prime-boost with an mRNA vaccine and an oncolytic virus enhances tumor regression through overcoming intratumoral immune suppression
by: Kuan Zhang, et al.
Published: (2025-06-01)

Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial
by: Lu Zhang, et al.
Published: (2025-01-01)

Inflammatory Response of THP1 and U937 Cells: The RNAseq Approach
by: Layla Panahipour, et al.
Published: (2024-12-01)

Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles
by: Mark S. Ferguson, et al.
Published: (2012-01-01)

A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome
by: Ian M. Bouligny, et al.
Published: (2025-02-01)

Impact of COVID-19 on the 937 Telephone Medical Consultation Service in Saudi Arabia
by: Najla J. Alhraiwil, et al.
Published: (2022-01-01)

Proteasome (Prosome) Subunit Variations during the Differentiation of Myeloid U937 Cells
by: Laurent Henry, et al.
Published: (1997-01-01)

Ipilimumab-induced thrombotic thrombocytopenic purpura (TTP)
by: Jeanelle King, et al.
Published: (2017-11-01)

The transcriptional regulation effects of histidine, isoleucine and glutamate on free exopolysaccharide biosynthesis of Streptococcus thermophilus 937
by: Yunchao Wa, et al.
Published: (2025-01-01)

Exploring the Effect of Resveratrol, Tyrosol, and Their Derivatives on Platelet-Activating Factor Biosynthesis in U937 Cells
by: Filio Petsini, et al.
Published: (2024-11-01)

Time Dependent Production of Cytokines and Eicosanoids by Human Monocytic Leukaemia U937 Cells; Effects of Glucocorticosteroids
by: Ingrid M. Garrelds, et al.
Published: (1999-01-01)

Vaccinia virus-regulated acute phase cytokine production in human fibroblasts, U937 cells and endothelium
by: H. Rokita, et al.
Published: (1998-01-01)

Viral Oncolytic Therapy
by: Omar Zurkiya, et al.
Published: (2017-07-01)

Rooperol tetraacetate decreases cytokine mRNA levels and binding capacity of transcription factors in U937 cells
by: A. Guzdek, et al.
Published: (1998-01-01)

Dynamics of REL, RELA and IRF1 transcription factor expression in U937 macrophages after dioxin exposure
by: E. V. Kashina, et al.
Published: (2017-02-01)

Engineered ipilimumab variants that bind human and mouse CTLA-4
by: Brett Robison, et al.
Published: (2025-12-01)

Intratumoral Immunotherapy in Breast Cancer
by: Camille C. Baumrucker, et al.
Published: (2025-04-01)

Clinical trials on oncolytic viruses
by: I. V. Golovinov, et al.
Published: (2025-01-01)

Translation of oncolytic viruses in sarcoma
by: Steven I. Robinson, et al.
Published: (2024-09-01)

ECDD-S16, a synthetic derivative of cleistanthin A, suppresses pyroptosis in Burkholderia pseudomallei-infected U937 macrophages.
by: Suphasuta Khongpraphan, et al.
Published: (2025-01-01)

Excellent Response to Nivolumab and Ipilimumab in Metastatic Gastroesophageal Junction Squamous Carcinoma
by: Narayanan Sadagopan, et al.
Published: (2019-01-01)

Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumab.
by: Dagmar von Bubnoff, et al.
Published: (2025-01-01)

Ipilimumab- and Nivolumab-Induced Colitis Causing Severe Hypokalemia and QTc Prolongation
by: David Anson, et al.
Published: (2019-01-01)

Treatment of Ipilimumab Induced Graves’ Disease in a Patient with Metastatic Melanoma
by: Umal Azmat, et al.
Published: (2016-01-01)

Re-exposition to ipilimumab plus nivolumab in metastatic Merkel cell carcinoma
by: Valerie Glutsch, et al.
Published: (2024-12-01)

Large‐cell neuroendocrine carcinoma of the kidney effectively treated by nivolumab and ipilimumab
by: Nodoka Okubo, et al.
Published: (2025-03-01)

Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells
by: Qin Yu, et al.
Published: (2022-12-01)

Renal Cell Carcinoma With Intratumoral Pseudoaneurysm
by: Daniel P. Pierce, et al.
Published: (2022-11-01)

Intratumoral heterogeneity and drug resistance in cancer
by: Yue-Chun Fu, et al.
Published: (2025-03-01)

Regional and intratumoral adoptive T-cell therapy
by: I. Olivera, et al.
Published: (2024-12-01)

Retargeting of Viruses to Generate Oncolytic Agents
by: M. H. Verheije, et al.
Published: (2012-01-01)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
by: Dipongkor Saha, et al.
Published: (2020-05-01)

Oncolytic Viruses in the Treatment of Bladder Cancer
by: Kyle G. Potts, et al.
Published: (2012-01-01)

NAVIGATING IPILIMUMAB-INDUCED HYPOPHYSITIS IN ADVANCED HEPATOCELLULAR CARCINOMA: A CLINICAL PERSPECTIVE
by: Luis Carlos Afonso Rocha, et al.
Published: (2025-04-01)

Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
by: Drew M Pardoll, et al.
Published: (2020-10-01)